New Zealand markets closed

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.65-0.10 (-1.29%)
At close: 04:00PM EDT
7.68 +0.03 (+0.39%)
After hours: 07:58PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-600,962
-583,196
-416,567
-346,790
-221,851
Depreciation & amortisation
18,386
18,512
18,260
14,238
12,739
Deferred income taxes
-
-
-4
-8
-2,938
Stock-based compensation
46,551
49,163
40,179
57,181
2,187
Change in working capital
-27,586
3,977
-8,001
-19,112
16,360
Accounts payable
-2,830
-6,476
8,000
-3,717
2,570
Other working capital
-412,846
-397,341
-436,900
-307,982
-173,393
Other non-cash items
93,680
95,503
35,311
18,104
14,132
Net cash provided by operating activities
-389,429
-366,757
-337,509
-274,419
-171,724
Cash flows from investing activities
Investments in property, plant and equipment
-23,417
-30,584
-99,391
-33,563
-1,669
Acquisitions, net
-
0
-1,000
0
0
Purchases of investments
-58,563
-10,358
-34,312
-141,750
-91,765
Sales/maturities of investments
24,372
10,472
162,000
69,929
73,622
Net cash used for investing activities
-57,608
-30,470
27,297
-84,886
-19,812
Cash flows from financing activities
Debt repayment
-79
-77
-58
0
0
Common stock issued
62,815
110,103
60,427
164,530
86,302
Common stock repurchased
-
-
-
0
0
Other financing activities
189,254
192,764
-339
1,016
-
Net cash used provided by (used for) financing activities
491,678
558,341
233,613
505,443
150,675
Net change in cash
44,564
160,822
-76,315
146,186
-40,886
Cash at beginning of period
88,805
104,965
181,280
35,094
75,980
Cash at end of period
133,446
265,787
104,965
181,280
35,094
Free cash flow
Operating cash flow
-389,429
-366,757
-337,509
-274,419
-171,724
Capital expenditure
-23,417
-30,584
-99,391
-33,563
-1,669
Free cash flow
-412,846
-397,341
-436,900
-307,982
-173,393